This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Biotech- and healthcare-related startups led the way as those companies dominate the list, taking a vast majority of spots. The company plans to use the new cash to expand in industries ranging from healthcare to autonomous vehicles and accelerate product innovation, including for its AI data intelligence platform. billion.
CEOs, CIOs and CFOs are finding that deep tech is actively driving business innovation and profitability. Artificialintelligence: Driving ROI across the board AI is the poster child of deep tech making a direct impact on business performance. According to a recent IDC study, companies using AI are reporting an average of $3.70
With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. One of the primary obstacles is the need for more highly skilled and qualified talent.
Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificialintelligence to biotech to energy. tied) Anthropic , $1B, artificialintelligence: Anthropic, a ChatGPT rival with its AI assistant Claude, is reportedly taking in a fresh $1 billion investment from previous investor Google.
xAI , $5B, artificialintelligence: Generative AI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported. Anthropic , $4B, artificialintelligence: Amazon has agreed to invest another $4 billion in AI startup Anthropic — a ChatGPT rival with its AI assistant Claude.
Insilico Medicine, a Hong Kong-based company that has been using artificialintelligence to discover new drugs since 2014, has completed a fresh round of funding. This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.”
The company plans to use the new cash to expand in industries ranging from healthcare to autonomous vehicles and accelerate product innovation, including for its AI data intelligence platform. Big money Of course this is far from the only play the Blackstone Group has made in the data sector. billion to develop data centers in Spain.
The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.
I’ve had many great positions throughout my career, in many different industries, from biotech to pharma to tech software companies, and currently at a medical device company. But you need to balance the innovation with the risk that comes along with it. From the innovation lens, I’m excited about AI. Then I started working.
Pika , $80M, artificialintelligence: It never takes us long to get to an AI startup on this list. Pika, an artificialintelligence startup that generates video, raised an $80 million round led by Spark Capital that values the Palo Alto, California-based company at $470 million, per Bloomberg.
In an increasingly hot biotech market, protecting IP is key. Partner at Tiger Global, John Curtius, added: “We are confident that Lifebit’s innovative and industry-leading software solutions, paired with their customer-first approach, will drive rapid global adoption and accelerate breakthroughs in precision medicine.”.
With the guidance and support of experienced executive search consultants, companies can strengthen their leadership teams and drive innovation, growth, and success in the life sciences industry. The rapid pace of innovation and advancement in the sector further compounds the challenges of leadership recruitment.
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. Then Alexey Ryazanov proposed the innovative idea of large-scale screening of all known pharmacological substances on long-lived mice in order to find those that prolong life.”.
Demand for executives who blend operational savvy, clinical literacy, and innovative thinking outpaces supply, pushing organizations to think creatively about leadership pipelines and succession planning. Fostering Innovation to Navigate Industry Transformation Few industries are as dynamically innovative as healthcare.
After a quiet holiday week, investors were back in action dishing out big rounds to startups in robotics, biotech, healthcare and more. Element Biosciences , $277M, biotech: It’s hard to get through a week without a big biotech raise, and this one’s no different. million Series B funding round led by Evok Innovations.
Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. Lambda , $320M, artificialintelligence: In a big week, this was the biggest round. The company offers cloud computing services and hardware for training artificialintelligence software. billion valuation.
Altana AI , $200M, supply chain management: Altana AI, a supply chain management startup, locked up a $200 million Series C investment led by the US Innovative Technology Fund that values the company at $1 billion. Outpace Bio , $144M, biotech: The big biotech raise of the week came from Outpace Bio.
The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations. A lot of this was incremental innovation around the user interface of coding assistants that developers have been using for 25 years,” says Sonnenblick.
Eight startups raised $100 million or more this week as a biotech and financial services company led the way. Saronic’s new round comes just about a week after Germany-based Helsing , which develops artificialintelligence software for defense, raised approximately $489 million in funding led by General Catalyst that valued the company at $5.4
While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Celestial AI , $175M, semiconductors: Optical interconnectivity startup Celestial AI raised a massive $175 million Series C led by Thomas Tull ’s US Innovative Technology Fund.
Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. Late last month, optical interconnectivity startup Celestial AI raised a massive $175 million Series C led by Thomas Tull ’s US Innovative Technology Fund.
April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. Augment , $227M, artificialintelligence: AI coding startups are making a big splash. Let’s take a look.
Artificialintelligence is having (another) moment — which means scrappy innovation is getting some deserved, if not buzzy, attention. 6 investors discuss why AI is more than just a buzzword in biotech. As AI pervades biotech, what are investors looking for in 2023? The impact of hype with Clubhouse’s Paul Davison.
In it, he argued that the internet will enable innovation on the same scale that electricity did. We are at a similar inflection point in healthcare, with the recent movement toward data transparency birthing a new generation of innovation and startups. What’s the main difference? And every physician in the U.S.
Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Now, certain industries are emerging as potential areas where New Zealand can win in the tech space. New Zealanders make really good founders.
Figure , $675M, artificialintelligence: Sunnyvale, California-based Figure last week confirmed earlier reports that it had raised a huge $675 million round at a $2.6 Lambda , $320M, artificialintelligence: Lambda hit unicorn status after a $320 million Series C at a $1.5 Founded in 2012, the company has raised $1.9
The influx of artificialintelligence in healthcare is exciting but often met with skepticism from the public, and rightfully so. Food and Drug Administration (FDA), startups can show investors and clients that they’ve gone through the necessary checks for safe use in healthcare, creating more opportunity to drive long-term success.
6 questions investors should ask when evaluating psychedelic biotech companies. 6 questions investors should ask when evaluating psychedelic biotech companies. Printing me softly with his song : Mostly known for its battery packs, Anker launches a Kickstarter campaign for its first 3D printer. You can sign up here.). Big Tech Inc.
X.AI , $135M, artificialintelligence: You may have heard Elon Musk has an artificialintelligence startup to compete with OpenAI. Seismic Therapeutic , $121M, biotech: Cambridge, Massachusetts-based Seismic Therapeutic led the way for biotechs this week — although it is far from the only biotech on this list.
Healthcare/biotech companies took the lead with three companies that joined the board from this sector. Google Ventures , US Innovative Technology Fund , General Catalyst , Founders Fund , Caffeinated Capital and angel investor Elad Gil each have two portfolio companies across this cohort. Who invested?
Two years ago, InstaDeep formed a multi-year strategic collaboration with BioNTech to launch a joint AI innovation lab. So, providing an intelligent system — which is one of InstaDeep’s applications — that can optimize train traffic, and manage constraints better, is highly marketable.
In such an environment, most would think the tech sector most greatly affected by the pullback would be deep tech — casually defined as cutting-edge scientific innovation that can create brand-new industries. This feels like a tough period … But there are big things happening quietly.”
“In addition to DNA storage, Catalog has already discovered the means to incorporate DNA into algorithms and applications with potential widespread cases including artificialintelligence, machine learning, data analytics and secure computing.
The fresh cash comes almost exactly a year after the company locked up a $175 million Series C led by Thomas Tull s US Innovative Technology Fund. Lila Sciences , $200M, life science: The intersection of artificialintelligence and science is seeing a lot of money, and this week we saw another example. at a reported $2.5
Despite its traditional image, agriculture is adopting new technological innovations and leveraging the cloud, big data, and the Internet of Things (IoT) solutions to increase productivity while protecting our environment. Intelligent software analysis for pest and disease prediction, soil management and other involved analytical tasks.
While we saw a lot of the regular sectors like biotech and financial services represented, we also saw some big deals involving supply chain and automotive startups. Element Biosciences , $277M, biotech: Every month there seems to be big biotech raises, and this one’s no different.
Sure, there are some, including two $3 billion deals in Q2: Merck buying privately held biotech EyeBiotech for as much as $3 billion, and Hg buying AuditBoard for more than $3 billion. Artificialintelligence is the driving reason chip giant Nvidia is now a $3 trillion-plus company. But there just haven’t been a lot.
The focus on foundational principles of protein function allows for an untapped level of bespoke protein design, adds Molly Gibson, co-founder and chief strategy innovation officer. . Still, generating antibodies is just part of the picture. That said, therapeutic proteins aren’t the easiest drugs to make.
“That’s really where we have innovated: we have built DragonFold, which is the first protein-ligand co-folding algorithm,” said Laskh Aithani, CEO and co-founder of Charm Therapeutics. “Designing drugs that bind to the disease-causing protein of interest very tightly and selectively (i.e.,
Yelda Kaya, formerly of J&J Innovation, will join as chief business officer. . Matheu calls it “natural intelligence” as opposed to artificialintelligence. . This Series B round was led by Celesta Capital and existing investor Khosla Ventures.
Artificialintelligence was big in 2023 — and that could be the understatement of the year. The round was led by Innovation Park ArtificialIntelligence , Bosch Ventures and the companies of Schwarz Group. It even has invested in a handful of biotech companies using AI. However, that’s why we’re here.
Some people are more excited by emerging areas like artificialintelligence, which has been a focus of the country’s military for years, and like cybersecurity is now producing many fresh teams of founders. A great amount of talent is cultivated in the military, which has spawned innovative cyber, AI and machine-learning companies.
tied) Accent Therapeutics , $75M, biotech: Another week, another big biotech round. The round included participation from some big brand names, such as Bristol Myers Squibb and Johnson & Johnson Innovation. tied) LB Pharmaceuticals , $75M, biotech: Accent wasn’t the only $75 million raise this week, as we had a trio.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content